Position in CELC
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$10,730,869
+$1,891,614 QoQ
Shares Held
94,015
+6.1% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 86.00542466627665.ToString("F0")%
Shared 0.ToString("F0")%
None 13.994575333723342.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,202,987,460 across 269 Biotechnology names. CELC ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in CELC
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,730,869 | 94,015 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,839,255 | 88,623 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,190,058 | 84,819 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $891,765 | 66,799 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $695,223 | 68,766 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $839,395 | 64,125 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $794,658 | 53,297 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,085,273 | 66,256 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,003,211 | 46,445 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $764,283 | 52,456 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $431,325 | 47,191 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $518,156 | 47,191 | Shares | Defined | 2023-08-03 | |
| 2022-03-31 | $265,156 | 28,359 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $363,766 | 27,579 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $390,204 | 21,678 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $391,392 | 16,308 | Shares | Defined | 2021-08-11 | |
| 2020-03-31 | $100,157 | 15,409 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||